Naveen K Mehta

5PUBLICATIONS
23CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Gene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 06, 2024
CLN-617 Retains IL2 and IL12 in Injected Tumors to Drive Robust and Systemic Immune-Mediated Antitumor Activity.

Naveen K Mehta, Kavya Rakhra, Kristan A Meetze

|Aug 16, 2023
CLN-978, a novel half-life extended CD19/CD3/HSA-specific T cell-engaging antibody construct with potent activity against B-cell malignancies with low CD19 expression.

Kristan Meetze, Naveen K Mehta, Bochong Li

|Mar 15, 2022
A novel IgG-based FLT3xCD3 bispecific antibody for the treatment of AML and B-ALL.

Naveen K Mehta, Martin Pfluegler, Kristan Meetze

|Jul 13, 2019
Enhanced CAR-T cell activity against solid tumors by vaccine boosting through the chimeric receptor.

Leyuan Ma, Tanmay Dichwalkar, Jason Y H Chang

|Jun 28, 2019
Anchoring of intratumorally administered cytokines to collagen safely potentiates systemic cancer immunotherapy.

Noor Momin, Naveen K Mehta, Nitasha R Bennett

Pageof 1

Frequent Collaborators

3 joint publications

K Dane Wittrup

2 joint publications

Noor Momin

2 joint publications

Leyuan Ma

2 joint publications

Darrell J Irvine